Compile Data Set for Download or QSAR
maximum 50k data
Found 45 Enz. Inhib. hit(s) with all data for entry = 50017141
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178014(CHEMBL370164 | N-(4-chlorophenyl)-2-(5-phenyl-7-(5...)
Affinity DataIC50:  0.200nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178003(CHEMBL370011 | N-cyclopropyl-2-(5-phenyl-7-(5-deox...)
Affinity DataIC50:  0.5nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178015(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  0.5nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50090887((1R,4S,5R)-2-Methyl-5-(5-phenyl-4-phenylamino-pyrr...)
Affinity DataIC50:  0.5nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178007(2-(5-phenyl-7-(beta-D-erythrofuranosyl)-pyrrolo[2,...)
Affinity DataIC50:  0.600nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178023(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  0.800nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178018(2-(3-phenyl-1-(beta-D-ribofuranosyl)-pyrazolo[3,4-...)
Affinity DataIC50:  0.900nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178027(CHEMBL438449 | N-cyclopentyl-2-(5-phenyl-7-(5-deox...)
Affinity DataIC50:  1nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178019(CHEMBL370654 | N-cyclobutyl-2-(5-phenyl-7-(5-deoxy...)
Affinity DataIC50:  1.30nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178013(CHEMBL372796 | N1-cyclopropyl-N2-(5-phenyl-7-(5-de...)
Affinity DataIC50:  1.30nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50090895((2R,3R,4S,5R)-2-[4-(4-Fluoro-phenylamino)-5-phenyl...)
Affinity DataIC50:  1.5nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50177990(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  2nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178005(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  2nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178008(CHEMBL198635 | N-cyclopropyl-2-(5-phenyl-7-(beta-D...)
Affinity DataIC50:  3nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178010(4-N-(N-cyclopropylcarbamoylmethyl)amino-5-phenyl-7...)
Affinity DataIC50:  3nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178021(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  4nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50177994(4-N-(propoxycarbonyl)amino-5-phenyl-7-(5-deoxy-bet...)
Affinity DataIC50:  4nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50177992(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  5nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50177998(CHEMBL381229 | N-(cyclopropylmethyl)-2-(5-phenyl-7...)
Affinity DataIC50:  6nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50177997(CHEMBL436096 | N-cyclopropyl-2-(3-phenyl-1-(5-deox...)
Affinity DataIC50:  6nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178022(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  7nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50177987(CHEMBL200457 | N-cyclopropyl-2-(3-phenyl-1-(beta-D...)
Affinity DataIC50:  10nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178011(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  16nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50177988(CHEMBL200196 | N-cyclopropyl-2-(5-phenyl-7-(beta-D...)
Affinity DataIC50:  20nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178004(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  25nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50177999(4-N-(3-N-methylureido)-5-phenyl-7-(5-deoxy-beta-D-...)
Affinity DataIC50:  27nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178020(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  38nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178025(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  40nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178017(4-(cyclopropylmethylamino)-5-phenyl-7-(5-deoxy-bet...)
Affinity DataIC50:  45nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178016(CHEMBL199371 | N-(4-chlorophenyl)-2-(7-((2-hydroxy...)
Affinity DataIC50:  60nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178024(5-phenyl-4-(propylamino)-7-(5-deoxy-beta-D-ribofur...)
Affinity DataIC50:  100nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178006(4-(isobutylamino)-5-phenyl-7-(5-deoxy-beta-D-ribof...)
Affinity DataIC50:  140nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50177995(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  145nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50177996(CHEMBL198698 | N-(2-(diethylamino)ethyl)-2-(5-phen...)
Affinity DataIC50:  210nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178012(2-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  300nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50090871(2-(4-Amino-5-phenyl-pyrrolo[2,3-d]pyrimidin-7-yl)-...)
Affinity DataIC50:  320nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178002(4-(cyclopropylamino)-5-phenyl-7-(5-deoxy-beta-D-ri...)
Affinity DataIC50:  380nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178026(CHEMBL372155 | N-cyclopropyl-2-(5-phenyl-7-(5-deox...)
Affinity DataIC50:  460nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178001((S)-N-cyclopropyl-2-(5-phenyl-7-(5-deoxy-beta-D-ri...)
Affinity DataIC50:  530nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178009(CHEMBL200352 | N-cyclopropyl-2-(5-iodo-7-(5-deoxy-...)
Affinity DataIC50:  880nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50090870(2-(4-Cyclohexylamino-5-phenyl-pyrrolo[2,3-d]pyrimi...)
Affinity DataIC50:  1.20E+3nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50177989(4-N-(N-cyclopropylcarbamoylmethyl)amino-5-phenyl-7...)
Affinity DataIC50:  1.70E+3nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50177991((R)-N-cyclopropyl-2-(5-phenyl-7-(5-deoxy-beta-D-ri...)
Affinity DataIC50:  2.50E+3nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50177993(3-(5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)-pyrro...)
Affinity DataIC50:  2.50E+3nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM50178000(CHEMBL371549 | N-cyclopropyl-2-(5-phenyl-7H-pyrrol...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibitory activity against recombinant human adenosine kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed